Skip To Main Content
Nicole Baranda on Muck Rack

Nicole Baranda

As seen in: Frontiers
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Nicole

Contact Nicole, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Efficacy of an XPO1 inhibitor in combination with irinotecan in a preclinical colorectal cancer model

|
By Nicole Baranda, S. Stephen, Adrian T. A
| Frontiers
Abstract Background: Irinotecan is a topoisomerase I inhibitor that is commonly used as a chemotherapeutic regimen for the treatment of metastatic colorectal cancer (CRC) by producing cytotoxic DNA damage. However, drug resistance frequently occurs, underscoring the importance of developing newer treatment strategies.
Open in Who Shared Issue with article?

Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice - Annals of Hematology

|
By Thomas Gregory, Brittany Knick, Nicole Baranda, Nilay Arvind
| link.springer.com
Abstract Polycythemia vera (PV) is a myeloproliferative neoplasm characterized by unregulated red blood cell production resulting in elevated hemoglobin and/or hematocrit levels. Patients often have symptoms such as fatigue, pruritus, and painful splenomegaly, but are also at risk of thrombosis, both venous and arterial.
Open in Who Shared Issue with article?
See all 2 articles